Synergistic endocrine induction by GLP-1 and TGF-β in the developing pancreas

Pancreas

Volumn 31, Issue 2, 2005, Pages 138-141

  Tei, Eri ^a,b   Mehta, Sheilendra ^a   Tulachan, Sidhartha S ^a   Yew, Hooi ^a   Hembree, Mark ^a   Preuett, Barry ^a   Snyder, Charles L ^a   Yamataka, Atsuyuki ^b   Miyano, Takeshi ^b   Gittes, George K ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Early developing pancreas; Glucagon like peptide 1; Transforming growth factor superfamily

Indexed keywords

AMYLASE; ANTIBODY; EXENDIN 4; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LIGAND; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ACINAR CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN SYNTHESIS; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG SYNERGISM; GLUCAGON-LIKE PEPTIDE 1; ISLETS OF LANGERHANS; MICE; MICE, INBRED STRAINS; PANCREAS, EXOCRINE; PEPTIDES; SIGNAL TRANSDUCTION; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VENOMS;

EID: 23044492149     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000172566.70619.58     Document Type: Article

References (12)

1. Perfetti R, Merkel P. Glucagon- like peptide-1: a major regulator of pancreatic beta-cell function. Eur J Endocrinol. 2000;143:717-725.
2. Gutniak MK, Linde B, Holst JJ, et al. Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM. Diabetes Care. 1994;17:1039-1044.
3. Hoist JJ. Gut hormones as pharmaceuticals. From enteroglucaon to GLP-1 and GLP-2. Regut Pept. 2000;93:45-51.
4. Massague J, Weis-Garcia F. Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv. 1996;27:41-64.
5. Massague J. TGFbeta signaling receptors, transducers, and Mad proteins. Cell. 1996;85:947-950.
6. van Laethem JL, Deviere J, Resibois A, et al. Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology. 1995;108:1873-1881.
7. Sanvito F, Herrera PL, Huarte J, et al. TGF-beta 1 influences the relative development of the exocrine and endocrine pancreas in vitro. Development. 1994;120:3451-3462.
8. Gittes GK, Rutter WJ. Onset of cell-specific gene expression in the developing mouse pancreas. Proc Natl Acad Sci USA. 1992;89:1128-1132.
9. Stoffers DA, Kieffer TJ, Hussain MA, et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes. 2000;49:741-748.
10. Xu G, Stoffers DA, Habener JF, et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes. 1999;48:2270-2276.
11. Nie Y, Nakashima M, Brubaker PL, et al. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats. J Clin Invest. 2000;105:955-965.
12. Yew KH, Prasadan KL, Preuett BL, et al. Interplay of glucagon-like peptide-1 and transforming growth factor-beta signaling in insulin-positive differentiation of AR42J cells. Diabetes. 2004;53:2824-2835.